Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Hememics Biotechnologies
708 Quince Orchard Rd., Suite 250A
Gaithersburg, MD 20878
https://www.hememics.com/

Hememics is a venture-backed biotechnology company that has developed a cellphone-sized POC device to pathogens in less than one minute. Due to a patented process for stabilizing antibodies on their proprietary chip, this technology does not require refrigeration. Coupled with its simplicity of operation, the device can be used anywhere - in the field or at bedside - to provide answers in seconds at the point of triage. The initial device in development is a point-of-care panel for STI. Inova Strategic Investments, the venture capital fund for the Inova Health System, is another significant investor in Hememics.

Key Contact
Name
John Warden
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
12/11/19 $2,500,000 AMVI Partners
undisclosed


Featured Reading